Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06283862 · ClinicalTrials.gov registry record · NA

MIVetsCan: Can-Coach Trial (Phase 2)

A NA study of Chronic Pain, sponsored by University of Michigan.

Recruiting
Registry status
NA
Development phase
468
Enrollment target
1
Study location

NCT06283862: Recruiting NA study of Chronic Pain, sponsored by University of Michigan.

NCT06283862 is a NA study of Chronic Pain that is actively recruiting participants, run by University of Michigan. The registered enrollment target is 468 participants, below the 771-participant average among 301 other Chronic Pain trials with a reported enrollment target (39% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06283862, a NA study of Chronic Pain, is actively recruiting participants, sponsored by University of Michigan.

RECRUITING
Registry status
NA
Development phase
468 participants
Enrollment target
1
Study location

Study Summary

The goal of the MIVetsCan Can-Coach Trial is to test four coaching sessions to help Veterans with chronic pain use their own cannabis products more effectively to manage pain and related symptoms.

Conditions Studied

Interventions

  • BEHAVIORAL Educational Session

Study Locations (1)

Michigan

  • University of Michigan - Ann Arbor

Trial Details

FieldValue
Enrollment Target 468 participants
Start Date 2024-04-04
Est. Completion 2027-02
Phase NA
University of Michigan

1,327 total trials

What NCT06283862 shows while recruiting

NCT06283862 is an interventional study that assigns participants to a tested intervention. The registered 468 participants enrollment target is mid-sized for trials with a published cap, below the 771-participant average among 301 other Chronic Pain trials with a reported enrollment target (39% lower).

The record links to 1 condition, with Chronic Pain appearing as the primary indexed condition, and to 1 intervention - of which Educational Session is the first listed.

NCT06283862 reports a single indexed study location in Michigan.

Frequently Asked Questions

What is clinical trial NCT06283862 about?

NCT06283862 is a clinical study titled "MIVetsCan: Can-Coach Trial (Phase 2)". The goal of the MIVetsCan Can-Coach Trial is to test four coaching sessions to help Veterans with chronic pain use their own cannabis products more effectively to manage pain and related symptoms.

What is the current status of trial NCT06283862?

This trial is currently recruiting. It is a NA study. The enrollment target is 468 participants. The study started on 2024-04-04. Estimated completion is 2027-02.

What conditions does trial NCT06283862 study?

This clinical trial studies the following conditions: Chronic Pain.

What interventions are being tested in trial NCT06283862?

The interventions under investigation include: Educational Session (BEHAVIORAL).

Who is sponsoring clinical trial NCT06283862?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06283862 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06283862's enrollment target sits among peer trials

468 23rd of 301 higher than 279 of 301 other Chronic Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Chronic Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03124303 · 468 participants

    Interventions for Postoperative Delirium: Biomarker-3

  • NCT03901924 · 468 participants · NA

    Volume Support/Assist Control Mode Ventilation and Diaphragmatic Atrophy

  • NCT04482309 · 468 participants · Phase 2

    A Phase 2 Study of T-DXd in Patients With Selected HER2 Expressing Tumors

  • NCT05357170 · 468 participants

    Microbiome Dysfunction in Surgical Intensive Care Unit Survivors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06283862, the US trial registry maintained by the National Library of Medicine. NCT06283862 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.